A stealthy approach to antineoplastic therapy Sophie Waghorn Newsletter Article 11 February 2013 Pages: 3 - 4
New report on pharmacotherapy for alcohol dependence Newsletter Article 11 February 2013 Pages: 6 - 6
Primary-care treatment of major depression - an update Newsletter Article 11 February 2013 Pages: 6 - 6
‘Great potential’ for self management of anticoagulation Newsletter Article 11 February 2013 Pages: 6 - 6
Usefulness of LHRH agonists in prostate cancer questioned Newsletter Article 11 February 2013 Pages: 7 - 7
M. vaccae vaccine promising in HIV-positive patients Newsletter Article 11 February 2013 Pages: 10 - 10
Candoxatril increases exercise capacity in heart failure Newsletter Article 11 February 2013 Pages: 10 - 10
Revealing raloxifene’s cardiovascular benefits Robyn Roper Newsletter Article 11 February 2013 Pages: 11 - 12
High-dose cyclophosphamide plus paclitaxel active in NHL Newsletter Article 11 February 2013 Pages: 12 - 12
Single-agent chemotherapy acceptable in breast cancer Newsletter Article 11 February 2013 Pages: 13 - 13
Amiodarone prevents new-onset AF in patients with CHF Newsletter Article 11 February 2013 Pages: 14 - 14
Lovastatin effective in adolescents with hypercholesterolaemia? Newsletter Article 11 February 2013 Pages: 16 - 16
Alteplase appears effective within 7 hours of stroke onset Newsletter Article 11 February 2013 Pages: 17 - 17
Anorectic-induced valvular heart disease risk assessed Newsletter Article 11 February 2013 Pages: 19 - 19
Major association between calcium antagonists and cancer unlikely Newsletter Article 11 February 2013 Pages: 19 - 19
New approach for effective communication in pharmacovigilance Jo Barnes Newsletter Article 11 February 2013 Pages: 20 - 21
No adverse effects in children after in utero/neonatal zidovudine exposure Newsletter Article 11 February 2013 Pages: 21 - 21